Omega Therapeutics, Inc. Common Stock
OMGA
OMGA was delisted on the 24th of February, 2025.
58 hedge funds and large institutions have $286M invested in Omega Therapeutics, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 16 increasing their positions, 15 reducing their positions, and 12 closing their positions.
34% more call options, than puts
Call options by funds: $227K | Put options by funds: $169K
33% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 12
7% more funds holding
Funds holding: 54 → 58 (+4)
7% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 15
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
6% less capital invested
Capital invested by funds: $303M → $286M (-$16.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$8.31M |
| 2 |
State Street
Boston,
Massachusetts
|
+$2.61M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.04M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$1.29M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$667K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCM
Laurion Capital Management
New York
|
-$4.28M |
| 2 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$1.07M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.06M |
| 4 |
Millennium Management
New York
|
-$985K |
| 5 |
Jane Street
New York
|
-$556K |
OMGA Hedge Fund Activity: Q2 2023 in Review
58 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Omega Therapeutics, Inc. Common Stock (OMGA) for Q2 2023, worth a combined $286M — down 5.5% from $303M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new OMGA positions and 12 closed out — a net gain of 4 holders — while 16 added to existing stakes and 15 trimmed.
The largest buyer was BlackRock, adding an estimated $8.31M. The largest seller was Laurion Capital Management, cutting an estimated $4.28M.
- 58 institutional investors held Omega Therapeutics, Inc. Common Stock (OMGA) as of Q2 2023, up from 54 in Q1 2023.
- Funds reported $286M of Omega Therapeutics, Inc. Common Stock stock for Q2 2023, down 5.5% quarter-over-quarter.
- 16 funds opened new Omega Therapeutics, Inc. Common Stock positions in Q2 2023 and 12 closed out, a net change of +4 holders.
- The largest Omega Therapeutics, Inc. Common Stock buyer in Q2 2023 was BlackRock, an estimated $8.31M added.
- The largest Omega Therapeutics, Inc. Common Stock seller in Q2 2023 was Laurion Capital Management, an estimated $4.28M sold.
Based on aggregated 13F filings for Q2 2023.